{"id":"tnf-alpha-inhibitors","safety":{"commonSideEffects":[{"rate":null,"effect":"Increased infection risk (including tuberculosis, fungal infections)"},{"rate":"10-20","effect":"Injection site reactions"},{"rate":"15-25","effect":"Upper respiratory tract infections"},{"rate":"10-15","effect":"Headache"},{"rate":null,"effect":"Malignancy risk (lymphoma, solid tumors)"},{"rate":null,"effect":"Demyelinating disease"},{"rate":null,"effect":"Heart failure exacerbation"}]},"_chembl":{"chemblId":"CHEMBL3897557","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"TNF-α is a central pro-inflammatory cytokine produced by macrophages, T cells, and other immune cells. By neutralizing or blocking TNF-α signaling through monoclonal antibodies, receptor antagonists, or TNF-α converting enzyme inhibitors, these drugs suppress excessive inflammatory responses. This mechanism is particularly effective in autoimmune and inflammatory conditions where TNF-α overproduction drives pathology.","oneSentence":"TNF alpha inhibitors block tumor necrosis factor-alpha, a key inflammatory cytokine that drives immune-mediated inflammation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:12:56.786Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Ankylosing spondylitis"},{"name":"Psoriatic arthritis"},{"name":"Crohn's disease"},{"name":"Ulcerative colitis"},{"name":"Psoriasis"},{"name":"Juvenile idiopathic arthritis"}]},"trialDetails":[{"nctId":"NCT00385086","phase":"PHASE3","title":"Lumbar Spinal Fibrosis and TNF Alpha Inhibition","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2007-02","conditions":"Post Operative Sciatica by Lumbar Spinal Fibrosis","enrollment":38},{"nctId":"NCT07293910","phase":"PHASE2","title":"Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-15","conditions":"HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":66},{"nctId":"NCT06538870","phase":"NA","title":"Dental Implant Healing With TNF-Alpha Inhibitors","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-06-28","conditions":"Edentulism, Dental Implants, TNF-alpha Inhibitors","enrollment":30},{"nctId":"NCT07250815","phase":"","title":"A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease","status":"NOT_YET_RECRUITING","sponsor":"Takeda","startDate":"2025-12-15","conditions":"Ulcerative Colitis, Crohn's Disease","enrollment":23900},{"nctId":"NCT03760003","phase":"PHASE2","title":"Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Abivax S.A.","startDate":"2019-08-13","conditions":"Ulcerative Colitis","enrollment":355},{"nctId":"NCT07237906","phase":"","title":"Neutropenia With TNF-α Inhibitors","status":"COMPLETED","sponsor":"Burak Ugur Cetin","startDate":"2023-09-01","conditions":"Neutropenia, TNF-alpha Inhibitors","enrollment":122},{"nctId":"NCT03792841","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC","status":"TERMINATED","sponsor":"Amgen","startDate":"2019-02-05","conditions":"Metastatic Castration-resistant Prostate Cancer, Prostate Cancer","enrollment":212},{"nctId":"NCT07021495","phase":"","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-07-29","conditions":"Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO)","enrollment":840},{"nctId":"NCT03011268","phase":"NA","title":"Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not?","status":"COMPLETED","sponsor":"Helse Møre og Romsdal HF","startDate":"2017-06-09","conditions":"Colitis,Ulcerative","enrollment":174},{"nctId":"NCT06686641","phase":"","title":"Incidence of Macular Edema in a Uveitis Population","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aalborg University Hospital","startDate":"2024-05-01","conditions":"Macular Edema, Non-infectious Uveitis","enrollment":1550},{"nctId":"NCT01793519","phase":"PHASE4","title":"Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Georgetown University","startDate":"2013-01","conditions":"Rheumatoid Arthritis","enrollment":290},{"nctId":"NCT05986903","phase":"","title":"Influence of HLA-DQA1*05 Genotype in Adults With Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring.","status":"UNKNOWN","sponsor":"Hospital del Rio Hortega","startDate":"2023-01-11","conditions":"Drug Monitoring, Inflammatory Bowel Diseases","enrollment":280},{"nctId":"NCT02822495","phase":"","title":"Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies","status":"NO_LONGER_AVAILABLE","sponsor":"Atara Biotherapeutics","startDate":"","conditions":"Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma","enrollment":""},{"nctId":"NCT05135312","phase":"PHASE4","title":"Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging","status":"UNKNOWN","sponsor":"OptiSkin Medical","startDate":"2021-08-09","conditions":"Psoriasis, Psoriatic Arthritis, Psoriatic Nail","enrollment":10},{"nctId":"NCT04973787","phase":"","title":"The Role of Microbiome on Biological Therapy Efficacy in axSpA and RA","status":"UNKNOWN","sponsor":"Universidade Nova de Lisboa","startDate":"2020-08-01","conditions":"Axial Spondyloarthritis, Arthritis, Rheumatoid","enrollment":90},{"nctId":"NCT03452501","phase":"","title":"Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients","status":"COMPLETED","sponsor":"Hikma Pharmaceuticals LLC","startDate":"2018-08-26","conditions":"Inflammatory Bowel Diseases, Crohn Disease, Fistulizing Crohn's Disease","enrollment":157},{"nctId":"NCT01548768","phase":"PHASE4","title":"RHYTHM (Formerly Escape II Myocardium)","status":"COMPLETED","sponsor":"Columbia University","startDate":"2011-10-10","conditions":"Rheumatoid Arthritis","enrollment":149},{"nctId":"NCT03348046","phase":"","title":"Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan","status":"COMPLETED","sponsor":"Hikma Pharmaceuticals LLC","startDate":"2017-03-23","conditions":"Rheumatoid Arthritis","enrollment":22},{"nctId":"NCT03001219","phase":"PHASE2","title":"A Study of RO7123520 to Evaluate the Safety and Efficacy in Participants With Moderately To Severely Active Rheumatoid Arthritis (RA) Who Are Inadequately Responding to Anti-Tumor Necrosis Factor (TNF)-Alpha Therapy","status":"TERMINATED","sponsor":"Hoffmann-La Roche","startDate":"2016-12-22","conditions":"Rheumatoid Arthritis","enrollment":109},{"nctId":"NCT02778789","phase":"","title":"Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers","status":"COMPLETED","sponsor":"University of Erlangen-Nürnberg Medical School","startDate":"2015-10","conditions":"Rheumatoid Arthritis","enrollment":66},{"nctId":"NCT03886233","phase":"","title":"Treatment Outcome of Uveitis in Autoimmune Diseases","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-03","conditions":"Autoimmune Uveitis","enrollment":1},{"nctId":"NCT02236481","phase":"PHASE4","title":"Clinical Study to Evaluate the Efficacy of Anakinra in Patients With Rheumatoid Arthritis and Diabetes","status":"TERMINATED","sponsor":"Prof. Roberto Giacomelli","startDate":"2013-07","conditions":"Diabetes Mellitus, Type 2, Arthritis, Rheumatoid","enrollment":41},{"nctId":"NCT03352622","phase":"NA","title":"Pharmacogenomic in Colombian Patients With Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"Universidad de Antioquia","startDate":"2017-10-17","conditions":"Pharmacological Action","enrollment":372},{"nctId":"NCT02765594","phase":"PHASE4","title":"Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2016-06","conditions":"Primary IgA Nephropathy","enrollment":98},{"nctId":"NCT00656292","phase":"PHASE4","title":"Assessing the Role of \"Statin\" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-04","conditions":"Perioperative Inflammatory Response","enrollment":61},{"nctId":"NCT03062865","phase":"","title":"French National Registry: ART REGISTRY (Observational Study)","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-11","conditions":"RheumatoId Arthritis","enrollment":1500},{"nctId":"NCT02694770","phase":"PHASE2","title":"A Study Evaluating the Efficacy and Safety of Neihulizumab vs \"Conventional Treatment\" to Treat Sr-aGvHD","status":"WITHDRAWN","sponsor":"AbGenomics B.V Taiwan Branch","startDate":"2016-07","conditions":"Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation","enrollment":""},{"nctId":"NCT00726804","phase":"PHASE4","title":"Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis","status":"TERMINATED","sponsor":"Glostrup University Hospital, Copenhagen","startDate":"2008-03","conditions":"SPONDYLOARTHRITIS","enrollment":7},{"nctId":"NCT02376478","phase":"","title":"On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2009-12","conditions":"Psoriasis, Inflammatory Bowel Diseases","enrollment":222},{"nctId":"NCT00597623","phase":"PHASE3","title":"Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients With Hand Osteoarthritis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-01","conditions":"Hand Osteoarthritis","enrollment":84},{"nctId":"NCT00478660","phase":"PHASE3","title":"An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY)","status":"COMPLETED","sponsor":"Abbott","startDate":"2006-02","conditions":"Ankylosing Spondylitis","enrollment":1250}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2002,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"TNF alpha inhibitors","genericName":"TNF alpha inhibitors","companyName":"Prof. Roberto Giacomelli","companyId":"prof-roberto-giacomelli","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TNF alpha inhibitors block tumor necrosis factor-alpha, a key inflammatory cytokine that drives immune-mediated inflammation. Used for Rheumatoid arthritis, Ankylosing spondylitis, Psoriatic arthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}